can you please elaborate on the 4,000 being the efficacious zone? based on what feedback from company did you come to that conclusion?
Ann: Positive safety data from 4th Cohort -Phase I Clinical Trial, page-10
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
46.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $102.0M | |||
| Open | High | Low | Value | Volume |
| 46.0¢ | 46.5¢ | 46.0¢ | $145.6K | 316.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 82151 | 46.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.5¢ | 57606 | 2 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| RCE (ASX) Chart |